🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

4 recruiting trials

for Immune Checkpoint Inhibitor-Related Colitis

Early Vedolizumab as First-Line for Immune-Related Colitis Therapy Trial NCT06841705Phase 22 sites📍 Boston📍 Boston Shilpa Grover, MD, MPH · Tests: Vedolizumab 300 MG Injection [Entyvio], Prednisone (and methylprednisolone), Prednisone Taper, Placebo Prednisone Capsu… Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients NCT06807593Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Ustekinumab Vedolizumab for the Prevention of ICI Related Diarrhea or Colitis in Patients With Cancer NCT06337695Phase 2, Phase 32 sites📍 Calgary📍 Edmonton AHS Cancer Control Alberta · Tests: Vedolizumab, Placebo A Pilot Study Testing the Safety and Feasibility of Restorative Microbiota Therapy (RMT) in Patients With Refractory Immune-checkpoint Inhibitor-related Colitis NCT05726396Phase 29 sites📍 Brainerd📍 Deer River📍 Detroit Lakes University of Minnesota · Tests: RMT, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy